Completed PHASE3 INTERVENTIONAL 2-arm NCT01505088

Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis

A Prospective, Multi-Center, Randomized, Double-Masked, Positive-Controlled Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients With Non-Infectious Anterior Segment Uveitis

Sponsor: Eyegate Pharmaceuticals, Inc.

Conditions Anterior Uveitis

Interventions 100 mM sodium citrate buffer solution 40 mg/mL Dexamethasone phosphate ophthalmic solution Placebo Eyedrops Prednisolone Acetate (1%) Eyedrops

Updated 6 times since 2017 Last updated: Mar 28, 2013 Started: Dec 31, 2011 Primary completion: Feb 28, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Anterior Uveitis and is currently completed. Eyegate Pharmaceuticals, Inc. leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eyegate Pharmaceuticals, Inc.

Data source: Eyegate Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Austin, United States , Baltimore, United States , Beverly Hills, United States , Birmingham, United States , Boston, United States , Bradenton, United States , Bridgeport, United States , Cambridge, United States , Chandler, United States and 27 more locations